BioMarin Pharmaceutical's chart data is dated 2026-10-09. There is no active technical signal. There are 6 published signal records.
BioMarin Pharmaceutical last closed at $54.80 (-0.17%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is 146.0×. Its overall grade ranks 490 of 738 stocks in Healthcare.
About this company
BioMarin Pharmaceutical last closed at $54.80 (-0.17%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 490/738
Valuation grade F
Related stocks
- RocheCompetitor
희귀질환·효소대체치료제 영역에서 경쟁
- SanofiCompetitor
희귀질환 및 유전자치료 관련 경쟁사
- PfizerCompetitor
희귀질환·전문의약품 파이프라인 경쟁
ETFs holding this stock
Global X Genomics And Biotechnology ETF
Details →About BioMarin Pharmaceutical
- What technical signals does BioMarin Pharmaceutical (BMRN) have?
- BioMarin Pharmaceutical current technical signals: no active technical signal.
- Is BioMarin Pharmaceutical a cup-and-handle pattern?
- No. BioMarin Pharmaceutical has no valid Cup signal right now.
- What published figures are available for BioMarin Pharmaceutical?
- Market cap: $10.53B. Trailing 12 months PER: 146.0×. Latest quarter PBR: 1.69×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about BioMarin Pharmaceutical, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.